Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal liposomal bupivacaine vs bupivacaine hydrochloride for postoperative pain
ChiCTR2500108264Phase 4Not yet recruiting
- Sponsor
- Zhongshan Hospital (Xiamen), Fudan University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Zhongshan Hospital (Xiamen), Fudan University. Primary endpoint: Total opioid consumption via patient-controlled analgesia in first 48 hours postoperatively. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500108264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108264.